Navigation Links
Scioderm Initiates Phase 2B Study of SD-101, A Novel Topical Therapy, for Patients with Epidermolysis Bullosa
Date:1/6/2014

the slightest friction or trauma.  This particular manifestation has led to EB patients being known as "butterfly children" due to the analogous nature of the fragility of the skin to the wings of a butterfly. As of today there is no cure or effective treatment.  The more severe forms of the disease lead to scarring, disfigurement, disability and early death, usually before the age of 30. 

About Scioderm, Inc.

Scioderm is a privately held, clinical-stage pharmaceutical company focused on developing innovative therapies to address diseases with critical unmet medical needs, including orphan products. The company is headquartered in Durham, North Carolina. Additional information about Scioderm can be found at www.sderm.com

About SD-101

SD-101 is a topical cream that has previously demonstrated potential to provide improvement in treating the severe skin effects seen in patients across all EB subtypes. An open-label Phase II study was conducted previously in children with either Simplex, Recessive Dystrophic (RDEB), or Junctional EB.  SD-101 was applied topically over the entire body daily for a period of three months. The primary outcome measurements were assessment of target wound reduction and closure, and reduction in body surface area (BSA) coverage of blisters and lesions.  In the clinical trial, SD-101 application resulted in complete closure of 88% of target chronic lesions within one month, in addition to a 57% reduction in BSA coverage of blisters and lesions after 3 months of daily treatment.   SD-101 was well tolerated by the children.

Forward Looking Statement

Except for the historical information contained herein, the matters discussed in this press release are forward-looking statements that involve risks and uncertainties, including: our dependence on third parties for the development, regulatory appro
'/>"/>

SOURCE Scioderm, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Scioderm Announces Positive Phase II Data of Topical SD-101 on Wound Closure and Reduction of Lesions and Blisters in Children with Epidermolysis Bullosa (EB)
2. Scioderms Investigational New Drug (IND) Application for SD-101 for Treatment of Epidermolysis Bullosa (EB) Allowed by the FDA
3. Scioderms SD-101 Receives Breakthrough Therapy Designation from FDA for Treatment of Epidermolysis Bullosa
4. Asubio Initiates Landmark Clinical Study in Spinal Cord Injury
5. CSL Behring Initiates Study of Subcutaneous Administration of C1-esterase Inhibitor in Patients with Hereditary Angioedema
6. Isis Initiates Phase 2 Study of ISIS-APOCIIIRx in Patients with Hypertriglyceridemia
7. Alder BioPharmaceuticals Inc. Initiates Phase 1 Clinical Study of Antibody Therapeutic Candidate for Treatment of Migraine, ALD403
8. Oncos Therapeutics Initiates Phase I Clinical Study of CGTG-102, an Oncolytic Adenovirus for the Treatment of Solid Tumor Cancers
9. MAQUET Initiates Class I Recall of the FLOW-i Anesthesia System
10. Stryker Initiates Voluntary Product Recall of Modular-Neck Stems
11. Inovio Initiates H1N1 Universal Influenza Vaccine Clinical Trial Targeting Over-65 Population, Which Represents 90% of Flu Deaths
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2014)... , Nov. 21, 2014  Abaxis, Inc. (NasdaqGS: ... instruments and consumables for the medical, research, and veterinary ... veterinary and research markets in the United ... stock purchase agreement to acquire 100% of QCR & ... based distribution organization. The transaction closed on November ...
(Date:11/21/2014)... Clementia Pharmaceuticals, Inc.  announced ... has granted Orphan Medicinal Product Designation for ... the treatment of fibrodysplasia ossificans progressiva (FOP). ... disease characterized by painful, recurrent episodes of ... bone formation. This process, known as heterotopic ...
(Date:11/21/2014)... YORK , Nov. 20, 2014  Market research firm ... the "Year of The Buy, in the medical device ... for medical devices will produce just 3% growth this ... actions, including acquisitions of product lines and entrance by ... annual survey of medical devices, The Global Market ...
Breaking Medicine Technology:Abaxis Acquires UK-based Distribution Organization 2Abaxis Acquires UK-based Distribution Organization 3Abaxis Acquires UK-based Distribution Organization 4Clementia Pharmaceuticals Receives EMA Orphan Medicinal Product Designation for Palovarotene for the Treatment of Fibrodysplasia Ossificans Progressiva 2Clementia Pharmaceuticals Receives EMA Orphan Medicinal Product Designation for Palovarotene for the Treatment of Fibrodysplasia Ossificans Progressiva 3Kalorama: 2014 The "Year of The Buy" in Medical Device Industry 2
... InfraReDx, Inc. , a medical device company ... publication of a case report in Circulation ... plaque as detected by its LipiScan™ Coronary Imaging System. ... to provide a Chemogram™ (map of lipid core plaque) ...
... Calif., Dec. 7, 2010 Cymetrix, a leader ... management solutions, today announced an alliance with Siemens ... In this new partnership, Cymetrix will assist in ... legacy patient accounting systems to Siemens Soarian®. Cymetrix,s ...
Cached Medicine Technology:InfraReDx Announces Publication of a Case Report in Circulation Highlighting Novel Clinical Finding with LipiScan™ Coronary Imaging System 2Cymetrix Forms Alliance With Siemens Healthcare for System Conversion Support 2
(Date:11/23/2014)... The FDA is Watching: , What Twitter, ... Dec. 11, 2014 ? Any Time at Your Convenience ... promotional activities is no longer limited to magazine and ... websites, Twitter, journal articles, TV appearances, Facebook and more. ... for On-Demand access to Timothy Ayers and Michelle Axelrod’s ...
(Date:11/22/2014)... SC (PRWEB) November 23, 2014 Every ... to their communities. AlignLife experience rapid growth in the ... a very unique opportunity. AlignLife of Simpsonville ... AlignLife offices for their first annual Toy Drive. These ... charity they would support with this year's toy drive. ...
(Date:11/22/2014)... November 23, 2014 A classic black prom ... the most famous dress suppliers, has unveiled its new items ... dresses are now offered at a big discount, up to ... offer. , The new black prom dresses, made with ... to meet the needs of all customers, the company provides ...
(Date:11/22/2014)... PA (PRWEB) November 22, 2014 “Due to ... said an inventor, from Gurnee, Ill. “While using the ice ... be and I thought there needed to be a safer ... invented the SPIKE BLOCK. , The SPIKE BLOCK offers added ... so, it would help to reduce injuries and damage associated ...
(Date:11/22/2014)... York (PRWEB) November 22, 2014 A ... morcellators ( http://www.morcellatorlawsuit2015.com ) in minimally-invasive hysterectomies and ... signatures since the end of October, Bernstein Liebhard LLP ... the petition as of November 21st, 2014. That represents ... 86,042 supporters had signed on to the campaign.* , ...
Breaking Medicine News(10 mins):Health News:FDAnews Announces The FDA is Watching: What Twitter, Tradeshows and TV Have in Common, On-Demand Webinar, Dec. 11, 2014 2Health News:FDAnews Announces The FDA is Watching: What Twitter, Tradeshows and TV Have in Common, On-Demand Webinar, Dec. 11, 2014 3Health News:FDAnews Announces The FDA is Watching: What Twitter, Tradeshows and TV Have in Common, On-Demand Webinar, Dec. 11, 2014 4Health News:FDAnews Announces The FDA is Watching: What Twitter, Tradeshows and TV Have in Common, On-Demand Webinar, Dec. 11, 2014 5Health News:Greenville Area AlignLife Offices Join Together for a Local Toy Drive 2Health News:New Black Prom Dresses from BellasDress.com 2Health News:Power Morcellator Petition Gains More than 450 Signatures Since October, Bernstein Liebhard LLP Reports 2Health News:Power Morcellator Petition Gains More than 450 Signatures Since October, Bernstein Liebhard LLP Reports 3Health News:Power Morcellator Petition Gains More than 450 Signatures Since October, Bernstein Liebhard LLP Reports 4
... of topical analgesic products -, MISSISSAUGA, ON, ... a Canadian drug development company focused on the ... through the skin using its,topical and transdermal drug ... exclusive rights from Paladin Labs Inc. (TSX: PLB) ...
... screen models for drugs to treat diseases , , THURSDAY, ... more efficient method of reprogramming adult stem cells to ... a human stem cell line containing the mutation associated ... cell lines can open the door for researchers who ...
... AUSTIN, Texas, May 29 Waving signs ... more than,20,000 petitions to the offices of Senators ... Austin, saying it,s time for Congress to halt,out-of-control ... ), Congress must act by June 30 ...
... University of North Carolina at Chapel Hill has received ... that will help speed up how scientific discoveries directly ... UNC is among 14 academic health centers in 11 ... and Translational Science Award (CTSA) consortium. By creating a ...
... 29 From June Dairy Month through,the State Fair, ... do.,Starting June 1, Minnesotans will be able get details ... the mouse. ExploreDairy.com is a,one-stop resource for all the ... 5,000 hardworking dairy farm families., ExploreDairy.com is designed ...
... is announcing its,plans to appeal a decision issued today ... favor of Whitehouse Station, N.J.-based Merck & Co.,(NYSE: ... jury,s determination,that the controversial painkiller Vioxx caused the death ... for less than nine months., "Activist judges are ...
Cached Medicine News:Health News:Nuvo licenses topical pain product from Paladin 2Health News:Nuvo licenses topical pain product from Paladin 3Health News:Researchers Develop Stem Line With Sickle Cell Mutation 2Health News:AARP Protests Medicare Premium Increases, Delivering Over 20,000 Petitions to Senators Hutchison and Cornyn 2Health News:AARP Protests Medicare Premium Increases, Delivering Over 20,000 Petitions to Senators Hutchison and Cornyn 3Health News:New federally-funded health initiative to speed benefits of science to North Carolinians 2Health News:ExploreDairy.com Debuts With Information on Minnesota Dairy Events, People and Products 2Health News:The Lanier Law Firm Will Appeal Court Reversal of Jury Award to Widow in Nation's 1st Vioxx Trial 2
Aire-Cuf® tracheostomy tubes are ideal for short-term to medium-term ventilator support....
Designed by a neonatalogist to reduce the number of steps required to suction meconium from the infants trachea when seconds count. Meconium suction system optimizes patient and provider safety....
KIMBERLY-CLARK BALLARD Neonatal and Pediatric TRACH CARE Manifold features lavage/irrigation port and locking thumb port. Multiple French sizes and packaging configurations. Gamma sterilized....
... Per-fit™ tubes are a dual ... of the disposable inner cannula ... provided in the procedural tray. ... tubes are available separately. Per-fit™ ...
Medicine Products: